A systematic review of skin substitutes for foot ulcers

Plastic and Reconstructive Surgery

Volumn 130, Issue 1, 2012, Pages 145-164

  Felder, John M ^a   Goyal, Samita S ^a   Attinger, Christopher E ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL SKIN; FOOT ULCER; HUMAN; METHODOLOGY; PLASTIC SURGERY; REVIEW; SKIN TRANSPLANTATION; WOUND HEALING;

FOOT ULCER; HUMANS; RECONSTRUCTIVE SURGICAL PROCEDURES; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; WOUND HEALING;

EID: 84863444415     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318254b1ea     Document Type: Review

References (29)

1. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999; 22 382-387.
2. Fan K, Tang J, Escandon J, Kirsner RS. State of the art in topical wound-healing products. Plast Reconstr Surg. 2011; 127 (Suppl 1) 44S-59S.
3. Lazic T, Falanga V. Bioengineered skin constructs and their use in wound healing. Plast Reconstr Surg. 2011; 127 (Suppl 1) 75S-90S.
4. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials Is blinding necessary? Control Clin Trials 1996; 17 1-12.
5. Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996; 19 350-354.
6. Sabolinski ML, Alvarez O, Auletta M, Mulder G, Parenteau NL. Cultured skin as a 'smart material' for healing wounds Experience in venous ulcers. Biomaterials 1996; 17 311-320.
7. Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs 1997; 21 1203-1210.
8. Pollak RA, Edington H, Jensen JL, Kroeker RO, Gentzkow GD. A human dermal replacement for the treatment of diabetic foot ulcers. Wounds 1997; 9 175-191.
9. Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol. 1998; 134 293-300.
10. Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999; 7 201-207.
11. Chang DW, Sanchez LA, Veith FJ, Wain RA, Okhi T, Suggs WD. Can a tissue-engineered skin graft improve healing of lower extremity foot wounds after revascularization? Ann Vasc Surg. 2000; 14 44-49.
12. Veves A, Falanga V, Armstrong DG, Sabolinski ML; Apligraf Diabetic Foot Ulcer Study. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers A prospective randomized multicenter clinical trial. Diabetes Care 2001; 24 290-295.
13. Marston WA, Hanft J, Norwood P, Pollak R; Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers Results of a prospective randomized trial. Diabetes Care 2003; 26 1701-1705.
14. Caravaggi C, De Giglio R, Pritelli C, et al. HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers A prospective, multicenter, controlled, randomized clinical trial. Diabetes Care 2003; 26 2853-2859.
15. Brigido SA, Boc SF, Lopez RC. Effective management of major lower extremity wounds using an acellular regenerative tissue matrix A pilot study. Orthopedics 2004; 27 s145-s149.
16. Brigido SA. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds A prospective 16-week pilot study. Int Wound J. 2006; 3 181-187.
17. Edmonds M; European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. Int J Low Extrem Wounds 2009; 8 11-18.
18. Reyzelman A, Crews RT, Moore JC, et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers A prospective, randomised, multicentre study. Int Wound J. 2009; 6 196-208.
19. Lipkin S, Chaikof E, Isseroff Z, Silverstein P. Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers Results of a multicenter pilot trial. Wounds 2003; 15 230-236.
20. DiDomenico L, Emch KJ, Landsman AR, Landsman A. A prospective comparison of diabetic foot ulcers treated with either cryopreserved skin allograft or bioengineered skin substitute. Wounds 2011; 23 184-189.
21. Bravo D, Rigley TH, Gibran N, Strong DM, Newman-Gage H. Effect of storage and preservation methods on viability in transplantable human skin allografts. Burns 2000; 26 367-378.
22. Langer A, Rogowski W. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Serv Res. 2009; 9 115.
23. Blozik E, Scherer M. Skin replacement therapies for diabetic foot ulcers Systematic review and meta-analysis. Diabetes Care 2008; 31 693-694.
24. Barber C, Watt A, Pham C, et al. Bioengineered Skin Substitutes for the Management of Wounds A Systematic Review. Adelaide, South Australia Australian Safety and Efficacy Register of New Interventional Procedures-Surgical, Royal Australasian College of Surgeons; 2006.
25. Barber C, Watt A, Pham C, et al. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes. J Wound Care 2008; 17 517-527.
26. Teng YJ, Li YP, Wang JW, et al. Bioengineered skin in diabetic foot ulcers. Diabetes Obes Metab. 2010; 12 307-315.
27. Heimbach D, Luterman A, Burke J, et al. Artificial dermis for major burns A multi-center randomized clinical trial. Ann Surg. 1988; 208 313-320.
28. Iorio ML, Goldstein J, Adams M, Steinberg J, Attinger C. Functional limb salvage in the diabetic patient The use of a collagen bilayer matrix and risk factors for amputation. Plast Reconstr Surg. 2011; 127 260-267.
29. Mueller MJ, Sinacore DR, Hastings MK, Strube MJ, Johnson JE. Effect of Achilles tendon lengthening on neuropathic plantar ulcers A randomized clinical trial. J Bone Joint Surg Am. 2003; 85 1436-1445.